【24h】

Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats

机译:通络散结凝胶局部治疗可减轻大鼠骨癌疼痛

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: The herbal analgesic gel Tong-Luo-San-Jie (TLSJ) and its modifications are used in traditional Chinese medicine to manage cancer pain. However, its mechanisms are still unknown. Aim of the study: To investigate the effects and mechanisms of TLSJ gel on bone cancer pain in a rat model. Materials and methods: A bone cancer pain rat model was established by inoculating Walker 256 rat carcinoma cells directly into the right tibial medullary cavity of Sprague-Dawley rats (150-170 g); Phosphate buffered saline (PBS) tibial inoculation was used as control. Cancer-bearing rats were treated twice a day with external TLSJ gel (0.5 g/cm 2/day) or inert gel control for 21 day (n=10/group). Behavioral tests such as mechanical threshold and paw withdrawal latency (PWL) were carried out. Osteoclastic activities were determined and carboxyterminal pyridinoline cross-linked type I collagen telopeptides (ICTP) and bone-specific alkaline phosphatase (BAP) concentrations were detected with ELISA after treatment. Adverse effects were monitored, and biochemical and histological tests were performed in na?ve rats treated with local TLSJ gel for six weeks. Results: TLSJ treatment significantly restored bone cancer-induced decrease of PWL and mechanical threshold compared to inert gel. It also decreased the level of blood serum ICTP and BAP and inhibited osteoclast activities. No adverse effects or abnormal biochemical and histological changes were detected after TLSJ treatment. Conclusion: The present study shows that TLSJ significantly inhibits bone cancer-induced thermal and mechanical sensitization. It suggests that the gel may be useful in managing cancer pain and that it may act by inhibiting osteoclastic activity.
机译:民族药理学相关性:中草药止痛药通络散结(TLSJ)及其修饰物在中药中用于治疗癌症疼痛。但是,其机制仍然未知。研究目的:研究TLSJ凝胶对大鼠骨癌疼痛的影响及其机制。材料和方法:通过将Walker 256大鼠癌细胞直接接种到Sprague-Dawley大鼠的右胫骨髓腔(150-170 g)中,建立骨痛模型。磷酸盐缓冲盐水(PBS)胫骨接种用作对照。每天两次用外部TLSJ凝胶(0.5 g / cm 2 /天)或惰性凝胶对照治疗荷癌大鼠21天(n = 10 /组)。进行了行为测试,例如机械阈值和爪缩回潜伏期(PWL)。治疗后测定破骨活性,并通过ELISA检测羧基末端吡啶啉交联的I型胶原蛋白端肽(ICTP)和骨特异性碱性磷酸酶(BAP)的浓度。监测不良反应,并在用局部TLSJ凝胶治疗6周的幼稚大鼠中进行生化和组织学测试。结果:与惰性凝胶相比,TLSJ治疗显着恢复了骨癌引起的PWL和机械阈值的降低。它还降低了血清ICTP和BAP的水平,并抑制了破骨细胞的活性。 TLSJ治疗后未发现不良反应或异常的生化和组织学变化。结论:本研究表明TLSJ显着抑制骨癌引起的热敏和机械敏化。这表明该凝胶可用于治疗癌症疼痛,并且它可能通过抑制破骨细胞活性发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号